Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trial

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Neural Transmission - Parkinsons Disease and Dementia Section

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02257620PMID 1540304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of tetrahydrofolate on tetrahydrobiopterin metabolism.

  2008cited by this paper
• Enhancement of recovery from psychiatric illness by methylfolate

  1992cited by this paper
• Enhancement of recovery from psychiatric illness by methylfolate.

  1990cited by this paper
• Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.

  1990cited by this paper
• Enhancement of Dopamine Release In Vivo from the Rat Striatum by Dialytic Perfusion of 6R‐l‐erythro‐5,6,7,8‐Tetrahydrobiopterin

  1990cited by this paper
• Psychosocial problems of Parkinson patients: approaches to assessment and treatment.

  1990cited by this paper
• Concentrations of neopterin and biopterin in the cerebrospinal fluid of patients with Parkinson's disease.

  1990cited by this paper
• Apomorphine test for dopaminergic responsiveness.

  1989cited by this paper
• APOMORPHINE TEST FOR DOPAMINERGIC RESPONSIVENESS

  1989cited by this paper
• Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy

  1989cited by this paper
• Stimulation of endogenous L‐dopa biosynthesis — a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)

  1989cited by this paper
• Serum and red blood cell folate in depression

  1989cited by this paper
• Tyrosine Hydroxylase Activity in Caudate Nucleus from Parkinson's Disease: Effects of Iron and Phosphorylating Agents

  1988cited by this paper
• Depression and disability in Parkinson's disease: a follow-up of 132 cases

  1988cited by this paper
• Folinic acid therapy in treatment of dihydropteridine reductase deficiency.

  1987cited by this paper
• Assessment of symptoms of Parkinson's disease by apparative methods.

  1987cited by this paper
• Absorption kinetics of orally administered leucovorin calcium.

  1987cited by this paper
• The biology of folate in depression: implications for nutritional hypotheses of the psychoses.

  1986cited by this paper
• Carences en folates chez les sujets âgés: intérêt de leur correction dans le traitement des troubles du comportement

  1986cited by this paper
• Clinical role of pteridine therapy in tetrahydrobiopterin deficiency

  1985cited by this paper
• Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.

  1984cited by this paper
• Tetrahydrobiopterin metabolism in depression.

  1984cited by this paper
• Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease.

  1984cited by this paper
• Methylation and mood.

  1984cited by this paper
• TETRAHYDROBIOPTERIN METABOLISM IN DEPRESSION

  1984cited by this paper
• Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin

  1983cited by this paper
• [Biopterin synthesis defects: complete deficiencies (reductase and synthetase)].

  1983cited by this paper
• Peripherally administered reduced pterins do enter the brain.

  1981cited by this paper
• A sibling case of hyperphenylalaninemia due to a deficiency of dihydropteridine reductase: biochemical and pathological findings.

  1980cited by this paper
• DIHYDROPTERIDINE REDUCTASE MAY FUNCTION IN TETRAHYDROFOLATE METABOLISM

  1978cited by this paper
• The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

  1975cited by this paper
• The phenylalanine hydroxylating system from mammalian liver.

  1971cited by this paper
• Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate.

  1971cited by this paper

• Initiation of treatment in early PD (evidences based)

  2011cites this paper
• Acute disseminated encephalomyelitis: Treatment guidelines

  2011influential citation
• Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2006cites this paper
• CME Practice Parameter : Neuroprotective strategies and alternative therapies for Parkinson disease ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2006cites this paper
• Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): [RETIRED]

  2006cites this paper
• Practice Parameter: Neuroprotect n ive Strategies and Alternative Therapies for Parkinso Disease (An Evidence-Based Review)

  2006cites this paper
• The use of alternative therapies by patients with Parkinson’s disease

  2001cites this paper